Marker Therapeutics, Inc (MRKR) Stock Price

3.08 ▼ -0.10 (-3.14%)
Open: 3.105 Vol: 220.85K Day's range: 3.025 - 3.105 Dec 13, 15:40 EST
IEX Real-Time Price
Loading chart ...
MRKR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 3.06▲ 3.07▲ 3.10▼ 3.18▼ 3.04▲
MA10 3.10▼ 3.14▼ 3.16▼ 3.15▼ 3.61▼
MA20 3.17▼ 3.19▼ 3.18▼ 3.05▲ 4.39▼
MA50 3.17▼ 3.14▼ 3.16▼ 3.69▼ N/A    
MA100 3.14▼ 3.11▼ 3.01▲ 4.42▼ N/A    
MA200 3.10▼ 3.10▼ 3.44▼ 5.34▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.016▼ -0.023▼ -0.022▼ 0.060▲ N/A    
RSI 40.237▼ 42.297▼ 42.642▼ 43.030▼ N/A    
STOCH 16.766▼ 9.150▼ 10.738▼ 55.805     14.131▼
WILL %R -78.431▼ -79.630▼ -79.630▼ -59.677     -88.041▼
CCI -54.799     -86.098     -112.447▼ -63.918     -83.484    
Latest Filters Detected On MRKR
CDL $MRKR Hammer Candlestick Pattern Detected Set Alert
GAP $MRKR Open Gap Down %2 Set Alert
MA $MRKR Price Crossed Below MA(7) Set Alert
MA $MRKR Price Crossed Below MA(13) Set Alert
Marker Therapeutics, Inc News
Friday, December 13, 2019 02:25 PM
One theme that investors love in good times and in bad is dividend investing. One strategy that has been around for years is known as the Dogs of the Dow.
Friday, December 13, 2019 09:26 AM
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Merck's (NYSE:MRK) Recarbio (imipenem/cilastatin/relebactam) for the treatment of ...
Thursday, December 12, 2019 04:32 AM
An exploratory analysis of the Phase 3 KEYNOTE-042 clinical trial evaluating Merck's (NYSE:MRK) Keytruda (pembrolizumab) as monotherapy versus chemo for the first-line treatment of metastatic ...
MRKR historical stock data
date open high low close volume
13/12/19 3.105 3.105 3.025 3.08 220,847
12/12/19 3.16 3.30 3.14 3.18 227,827
11/12/19 3.28 3.28 3.14 3.20 276,912
10/12/19 3.22 3.30 3.14 3.28 291,807
09/12/19 3.13 3.255 3.07 3.17 248,587
06/12/19 3.10 3.18 3.02 3.09 175,200
05/12/19 3.20 3.20 3.0538 3.12 189,566
04/12/19 3.11 3.19 2.92 3.17 377,300
03/12/19 3.12 3.22 2.86 3.00 591,300
02/12/19 3.38 3.38 3.12 3.17 362,800
Quote Details
52wk Low:2.61
52wk High:9.165
Vol:220.85K
Avg Vol(3m):5.8M
1Y Chng:+0.00%
1M Chng:-25.60%
Add to Watch List